Efficacy and safety of telotristat etiprate in patients with carcinoid syndrome not adequately controlled by somatostatin analog therapy: analysis of the ongoing TELESTAR extension period.
Authors
Hrsch, DKulke, M
Caplin, M
Anthony, L
Bergsland, E
Oberg, K
Welin, S
Warner, R
Lombard-Bohas, C
Kunz, P
Valle, Juan W
Fleming, D
Lapuerta, P
Banks, P
Pavel, M
Affiliation
Zentralklinik Bad Berka, Bad Berka, GermanyIssue Date
2016